Skip to content

VersaCross Large Access Solution VLAK0014Recalls & reported problems

Baylis Médicale Cie Inc · 1 x VersaCross Large Access Transseptal Dilator (including 1 x J-tip Mechanical Guidewire); 1 x VersaCross RF Wire (including 1 x Connector Cable (Single Use)) · Class 2

Adverse event reports
5
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00685447012535), received between Apr 13, 2023 and Sep 12, 2024 — classified as 5 malfunctions.

The most frequently reported specific device problem is “Device-Device Incompatibility” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 1 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Device-Device Incompatibility2
  • Device Contaminated During Manufacture or Shipping1
  • Difficult to Advance1
  • Difficult to Remove1
  • Physical Resistance/Sticking1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3
  • Perforation2
  • Thrombosis/Thrombus2

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 12, 2024Device Contaminated During Manufacture or Shipping; Device Contaminated During Manufacture or Shipping

    IT WAS REPORTED THAT A VERSACROSS LARGE ACCESS SOLUTION KIT WAS SELECTED FOR ATRIAL FIBRILLATION (A FIB) ABLATION. PRIOR TO THE PROCEDURE, DURING PREPARATION, IT WAS MENTIONED THAT WHEN THE STERILE PACKAGING FOR THE KIT WAS OPENED, A LOOSE LONG BLACK HAIR WAS OBSERVED TO BE INSIDE THE STERILE PACKAGING. THUS, THE DEVICE WAS REPLACED, AND THE PROCEDURE WAS COMPLETED SUCCESSFULLY. NO PATIENT COMPLICATIONS WERE REPORTED. THE DEVICE IS EXPECTED TO BE RETURNED FOR ANALYSIS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20207941 ↗
  • MalfunctionApr 15, 2024Device-Device Incompatibility; Difficult to Advance; Adverse Event Without Identified Device or Use Problem; Device-Device Incompatibility; Difficult to Advance; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT DURING THE INSERTION OF THE MITRA CLIP PROCEDURE TO TREAT MITRAL VALVE, A VERSACROSS LARGE ACCESS SOLUTION KIT WAS SELECTED FOR USE. IT HAS BEEN MENTIONED THAT VERSACROSS DILATOR WAS NOT ABLE TO BE FRONT LOAD WITH THE VERSACROSS RF WIRE. THE TROUBLESHOOTING STEPS INCLUDED BACK LOADING THE DILATOR. THE PROCEDURE WAS COMPLETED SUCCESSFULLY BY USING ANOTHER VERSACROSS KIT. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED. THE PRODUCT WAS EXPECTED TO BE RETURNED. HOWEVER, ANALYSIS OF THE DEVICE RETURNED REVEALED A SCUFFING OF THE DILATOR CURVE, AND A MINOR TIP DEFECT OUTSIDE OF LUMEN, EXTRA MATERIAL NOTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19106884 ↗
  • MalfunctionAug 17, 2023Difficult to Remove; Device-Device Incompatibility; Physical Resistance/Sticking; Difficult to Remove; Device-Device Incompatibility; Physical Resistance/Sticking

    IT WAS REPORTED THAT DURING A LEFT ATRIAL APPENDAGE CLOSURE (LAAC) PROCEDURE, A VERSACROSS LARGE ACCESS KIT WAS SELECTED FOR USE. THE MECHANICAL GUIDEWIRE WAS ADVANCED INTO THE SUPERIOR VENA CAVA (SVC) AND THE DILATOR WAS POSITIONED. WHEN THE PHYSICIAN ATTEMPTED TO REMOVE THE GUIDEWIRE, IT GOT STUCK IN THE DILATOR. HENCE THE ALL DEVICES WERE REMOVED TOGETHER. THE PHYSICIAN TRIED FORCING TO PULL THE WIRE USING FORCEPS AND IT CAME FREE FROM THE DILATOR. TO RESOLVE THE ISSUE, A NEW VERSACROSS LARGE ACCESS KIT WAS OPENED AND THE PROCEDURE WAS COMPLETED SUCCESSFULLY. NO PATIENT COMPLICATIONS OCCURRED. THE DEVICE IS EXPECTED TO BE RETURNED FOR ANALYSIS. IT WAS FURTHER CLARIFIED THERE WERE NO DAMAGE NOTED TO THE WIRE WHEN IT WAS REMOVED FROM PACKAGING OR BODY. THE GUIDEWIRE WAS TRACKED FROM THE RIGHT GROIN VENOUS ACCESS SITE TO THE SVC BUT NO DIFFICULTY NOTED WITH PATIENT ANATOMY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17565312 ↗
  • MalfunctionAug 4, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT DURING A PROCEDURE TO TREAT ATRIAL FIBRILLATION, THE TRANSEPTAL PUNCTURE WAS THEN PERFORMED AND UPON CROSSING THE INTERATRIAL SEPTUM (IAS), A VERSACROSS RF WIRE WAS SENT INTO THE LEFT INFERIOR PULMONARY VEIN (LIPV), BUT THE VERSACROSS RF WIRE HIT THE TIP OF THE LIMBUS. THE VERSACROSS SYSTEM WAS EXCHANGED FOR THE WATCHMAN TRUSEAL DOUBLE CURVE SHEATH, BUT PRIOR TO THE WATCHMAN SHEATH CROSSING THE IAS, IT WAS NOTED THAT A SMALL HYPERMOBILE ECHODENSITY HAD FORMED ON THE TIP OF THE LIMBUS. IT MEASURED APPROXIMATELY 3.5 MM IN LENGTH. THE WATCHMAN SHEATH WAS STILL CROSSED INTO THE LEFT ATRIUM (LA), THE VERSACROSS RF WIRE WAS PULLED BACK AND REPLACED WITH A NON-BOSTON SCIENTIFIC PIGTAIL CATHETER INTO THE LEFT ATRIAL APPENDAGE (LAA). THE AFOREMENTIONED HYPERMOBILE ECHODENSITY WAS CONTINUOUSLY OBSERVED AND AT THIS TIME WAS DEEMED A CLOT. ADDITIONAL HEPARIN WAS GIVEN AND AFTER ROUGHLY 5-10 MINUTES THE DECISION WAS MADE TO CANCEL THE PROCEDURE. IT WAS STATED THAT THIS WAS CAUSED BY THE WIRE HITTING THE TIP OF THE LIMBUS AND THAT THE PATIENT WAS LIKELY HYPERCOAGULABLE. ANOTHER PROCEDURE WILL BE SCHEDULED. THE PATIENT IS STABLE AND DOING WELL. THE DEVICE WILL NOT BE RETURNED

    Patient problems: Perforation; Thrombosis/Thrombus

    MAUDE report 17459418 ↗
  • MalfunctionApr 13, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT DURING A PROCEDURE TO TREAT ATRIAL FIBRILLATION, THE TRANSEPTAL PUNCTURE WAS THEN PERFORMED AND UPON CROSSING THE INTERATRIAL SEPTUM (IAS), A VERSACROSS RF WIRE WAS SENT INTO THE LEFT INFERIOR PULMONARY VEIN (LIPV), BUT THE VERSACROSS RF WIRE HIT THE TIP OF THE LIMBUS. THE VERSACROSS SYSTEM WAS EXCHANGED FOR THE WATCHMAN TRUSEAL DOUBLE CURVE SHEATH, BUT PRIOR TO THE WATCHMAN SHEATH CROSSING THE IAS, IT WAS NOTED THAT A SMALL HYPERMOBILE ECHODENSITY HAD FORMED ON THE TIP OF THE LIMBUS. IT MEASURED APPROXIMATELY 3.5 MM IN LENGTH. THE WATCHMAN SHEATH WAS STILL CROSSED INTO THE LEFT ATRIUM (LA), THE VERSACROSS RF WIRE WAS PULLED BACK AND REPLACED WITH A NON-BOSTON SCIENTIFIC PIGTAIL CATHETER INTO THE LEFT ATRIAL APPENDAGE (LAA). THE AFOREMENTIONED HYPERMOBILE ECHODENSITY WAS CONTINUOUSLY OBSERVED AND AT THIS TIME WAS DEEMED A CLOT. ADDITIONAL HEPARIN WAS GIVEN AND AFTER ROUGHLY 5-10 MINUTES THE DECISION WAS MADE TO CANCEL THE PROCEDURE. IT WAS STATED THAT THIS WAS CAUSED BY THE WIRE HITTING THE TIP OF THE LIMBUS AND THAT THE PATIENT WAS LIKELY HYPERCOAGULABLE. ANOTHER PROCEDURE WILL BE SCHEDULED. THE PATIENT IS STABLE AND DOING WELL. THE DEVICE WILL NOT BE RETURNED

    Patient problems: Perforation; Thrombosis/Thrombus

    MAUDE report 16735264 ↗

Other Catheter, Septostomy devices

All Catheter, Septostomy devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.